Skip to main content

Hologic Value Stock - Dividend - Research Selection

Hologic

ISIN: US4364401012 , WKN: 879100

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. It offers Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and related products, and accessories comprising digital and film-based mammography systems; computer-aided detection for mammography; minimally invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. In addition, it offers Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D, a software product that provides 2D images; Selenia digital mammography platform; and SecurView Workstation. Further, it provides SculpSure, MonaLisa Touch, Vectus diode, and Cellulaze laser devices; PicoSure and Icon aesthetic systems; MedLite, RevLite, Cynergy, Elite, and SmartLipo products; and system components. Additionally, it offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient\'s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


FDA classifies Hologic’s recall of BioZorb Marker as Class I

2024-05-23
The BioZorb Marker has been distributed from 29 April 2019 to 1 April 2024.

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio

2024-05-23
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These stocks are: ALC, RXST, HOLX, VCYT, MASI.

Hologic recalls more than 53,000 radiographic markers linked to 71 injuries

2024-05-23
The Biozorb devices are staying on the market, but Hologic has asked people to report adverse events such as pain.

FDA classifies recall of Hologic's implant as 'most serious'

2024-05-22
The U.S. Food and Drug Administrationon Wednesday classified a recall of Hologic's devicesthat are implanted in soft tissue such as breast tissue as mostserious, and urged doctors to more actively...

FDA classifies recall of Hologic's implants for soft tissue as 'most serious'

2024-05-22
The U.S. Food and Drug Administrationon Wednesday classified a recall of Hologic's devicesthat are implanted in soft tissue such as breast tissue as mostserious.(Reporting by Mariam Sunny in...

Hologic recalls BioZorb Marker due to complications with implanted devices

2024-05-22
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Hologic’s recall of BioZorb Markers classified as FDA’s most serious type

2024-05-22
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Hologic to Webcast Presentations at Upcoming Investor Conferences

2024-05-21
MARLBOROUGH, Mass., May 21, 2024--Hologic to Webcast Presentations at Upcoming Investor Conferences

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

2024-05-20
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Hologic Inc. stock underperforms Thursday when compared to competitors despite daily gains

2024-05-16
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.